HEADER TRANSFERASE 16-JUN-20 7CC2 TITLE STRATEGIC DESIGN OF CATALYTIC LYSINE-TARGETING REVERSIBLE COVALENT TITLE 2 BCR-ABL INHIBITORS COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TYROSINE KINASE COVALENT INHIBITOR CHRONIC MYELOGENOUS LEUKEMIA, KEYWDS 2 TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR J.ANANTHARAJAN,N.BABURAJENDRAN REVDAT 3 29-NOV-23 7CC2 1 REMARK REVDAT 2 28-JUL-21 7CC2 1 JRNL REVDAT 1 09-JUN-21 7CC2 0 JRNL AUTH D.QUACH,G.TANG,J.ANANTHARAJAN,N.BABURAJENDRAN,A.POULSEN, JRNL AUTH 2 J.L.K.WEE,P.RETNA,R.LI,B.LIU,D.H.Y.TEE,P.Z.KWEK,J.K.JOY, JRNL AUTH 3 W.Q.YANG,C.J.ZHANG,K.FOO,T.H.KELLER,S.Q.YAO JRNL TITL STRATEGIC DESIGN OF CATALYTIC LYSINE-TARGETING REVERSIBLE JRNL TITL 2 COVALENT BCR-ABL INHIBITORS*. JRNL REF ANGEW.CHEM.INT.ED.ENGL. V. 60 17131 2021 JRNL REFN ESSN 1521-3773 JRNL PMID 34008286 JRNL DOI 10.1002/ANIE.202105383 REMARK 2 REMARK 2 RESOLUTION. 2.72 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.11.1_2575 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.72 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.39 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.360 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 23343 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.196 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.242 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.570 REMARK 3 FREE R VALUE TEST SET COUNT : 2000 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 47.3900 - 6.5571 0.99 1641 154 0.1943 0.2659 REMARK 3 2 6.5571 - 5.2067 1.00 1558 147 0.2047 0.2337 REMARK 3 3 5.2067 - 4.5491 1.00 1563 145 0.1684 0.1986 REMARK 3 4 4.5491 - 4.1335 1.00 1528 144 0.1670 0.1860 REMARK 3 5 4.1335 - 3.8373 1.00 1532 143 0.1744 0.2289 REMARK 3 6 3.8373 - 3.6112 1.00 1514 142 0.1860 0.2343 REMARK 3 7 3.6112 - 3.4304 1.00 1517 142 0.1817 0.2100 REMARK 3 8 3.4304 - 3.2811 1.00 1507 142 0.2006 0.2378 REMARK 3 9 3.2811 - 3.1548 1.00 1502 140 0.2051 0.3152 REMARK 3 10 3.1548 - 3.0460 1.00 1512 142 0.2015 0.2496 REMARK 3 11 3.0460 - 2.9507 1.00 1493 140 0.2211 0.2843 REMARK 3 12 2.9507 - 2.8664 1.00 1515 141 0.2152 0.2986 REMARK 3 13 2.8664 - 2.7910 0.99 1488 140 0.2290 0.3121 REMARK 3 14 2.7910 - 2.7230 0.99 1473 138 0.2615 0.3555 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.330 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.530 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.73 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 46.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4418 REMARK 3 ANGLE : 0.676 5985 REMARK 3 CHIRALITY : 0.045 643 REMARK 3 PLANARITY : 0.003 746 REMARK 3 DIHEDRAL : 5.494 2596 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: (CHAIN A AND (RESID 233 THROUGH 237 OR REMARK 3 (RESID 238 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 239 REMARK 3 THROUGH 262 OR (RESID 263 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 264 THROUGH 285 OR (RESID 286 REMARK 3 THROUGH 288 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 289 THROUGH 395 OR (RESID 396 THROUGH 397 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR (RESID 398 THROUGH 400 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )) OR RESID 401 THROUGH 443 REMARK 3 OR (RESID 444 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 445 THROUGH 461 OR (RESID 462 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 )) OR RESID 463 THROUGH 501)) REMARK 3 SELECTION : (CHAIN B AND (RESID 233 THROUGH 248 OR REMARK 3 RESID 255 THROUGH 277 OR (RESID 278 REMARK 3 THROUGH 283 AND (NAME N OR NAME CA OR REMARK 3 NAME C OR NAME O OR NAME CB )) OR RESID REMARK 3 284 THROUGH 306 OR (RESID 307 AND (NAME N REMARK 3 OR NAME CA OR NAME C OR NAME O OR NAME CB REMARK 3 OR NAME CG )) OR RESID 308 THROUGH 372 OR REMARK 3 (RESID 373 AND (NAME N OR NAME CA OR NAME REMARK 3 C OR NAME O OR NAME CB )) OR RESID 374 REMARK 3 THROUGH 408 OR (RESID 409 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 410 THROUGH 414 OR (RESID 415 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB OR NAME CG )) OR RESID 416 REMARK 3 THROUGH 458 OR (RESID 459 AND (NAME N OR REMARK 3 NAME CA OR NAME C OR NAME O OR NAME CB )) REMARK 3 OR RESID 460 THROUGH 500 OR (RESID 501 REMARK 3 AND (NAME N OR NAME CA OR NAME C OR NAME REMARK 3 O OR NAME CB )))) REMARK 3 ATOM PAIRS NUMBER : 2398 REMARK 3 RMSD : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CC2 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 18-JUN-20. REMARK 100 THE DEPOSITION ID IS D_1300017313. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 28-OCT-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.95374 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS 0.7.2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23393 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.720 REMARK 200 RESOLUTION RANGE LOW (A) : 47.395 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.700 REMARK 200 R MERGE (I) : 0.14400 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.72 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.6 REMARK 200 DATA REDUNDANCY IN SHELL : 6.80 REMARK 200 R MERGE FOR SHELL (I) : 0.75300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 2QOH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7 % W/V POLYETHYLENE GLYCOL 8000, 100 REMARK 280 MM MES PH 6.5, 20 % V/V ETHYLENE GLYCOL, VAPOR DIFFUSION, REMARK 280 HANGING DROP, TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 58.24450 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 63.96950 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 58.24450 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 63.96950 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 201 REMARK 465 GLY A 202 REMARK 465 SER A 203 REMARK 465 SER A 204 REMARK 465 HIS A 205 REMARK 465 HIS A 206 REMARK 465 HIS A 207 REMARK 465 HIS A 208 REMARK 465 HIS A 209 REMARK 465 HIS A 210 REMARK 465 SER A 211 REMARK 465 SER A 212 REMARK 465 GLY A 213 REMARK 465 LEU A 214 REMARK 465 VAL A 215 REMARK 465 PRO A 216 REMARK 465 ARG A 217 REMARK 465 GLY A 218 REMARK 465 SER A 219 REMARK 465 HIS A 220 REMARK 465 MET A 221 REMARK 465 GLU A 222 REMARK 465 ASN A 223 REMARK 465 LEU A 224 REMARK 465 TYR A 225 REMARK 465 PHE A 226 REMARK 465 GLN A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 TYR A 232 REMARK 465 GLY A 249 REMARK 465 GLY A 250 REMARK 465 GLY A 251 REMARK 465 GLN A 252 REMARK 465 TYR A 253 REMARK 465 GLY A 254 REMARK 465 ILE A 502 REMARK 465 SER A 503 REMARK 465 ASP A 504 REMARK 465 GLU A 505 REMARK 465 VAL A 506 REMARK 465 GLU A 507 REMARK 465 LYS A 508 REMARK 465 GLU A 509 REMARK 465 LEU A 510 REMARK 465 MET B 201 REMARK 465 GLY B 202 REMARK 465 SER B 203 REMARK 465 SER B 204 REMARK 465 HIS B 205 REMARK 465 HIS B 206 REMARK 465 HIS B 207 REMARK 465 HIS B 208 REMARK 465 HIS B 209 REMARK 465 HIS B 210 REMARK 465 SER B 211 REMARK 465 SER B 212 REMARK 465 GLY B 213 REMARK 465 LEU B 214 REMARK 465 VAL B 215 REMARK 465 PRO B 216 REMARK 465 ARG B 217 REMARK 465 GLY B 218 REMARK 465 SER B 219 REMARK 465 HIS B 220 REMARK 465 MET B 221 REMARK 465 GLU B 222 REMARK 465 ASN B 223 REMARK 465 LEU B 224 REMARK 465 TYR B 225 REMARK 465 PHE B 226 REMARK 465 GLN B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 GLY B 249 REMARK 465 GLY B 250 REMARK 465 GLY B 251 REMARK 465 GLN B 252 REMARK 465 ILE B 502 REMARK 465 SER B 503 REMARK 465 ASP B 504 REMARK 465 GLU B 505 REMARK 465 VAL B 506 REMARK 465 GLU B 507 REMARK 465 LYS B 508 REMARK 465 GLU B 509 REMARK 465 LEU B 510 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 275 CG CD OE1 OE2 REMARK 470 MET A 278 CG SD CE REMARK 470 GLU A 279 CG CD OE1 OE2 REMARK 470 VAL A 280 CG1 CG2 REMARK 470 GLU A 281 CG CD OE1 OE2 REMARK 470 GLU A 282 CG CD OE1 OE2 REMARK 470 PHE A 283 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 307 CD NE CZ NH1 NH2 REMARK 470 GLU A 373 CG CD OE1 OE2 REMARK 470 GLU A 409 CG CD OE1 OE2 REMARK 470 LYS A 415 CD CE NZ REMARK 470 GLU A 459 CG CD OE1 OE2 REMARK 470 SER A 501 OG REMARK 470 TYR B 232 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 GLU B 275 CG CD OE1 OE2 REMARK 470 GLU B 279 CG CD OE1 OE2 REMARK 470 GLU B 286 CG CD OE1 OE2 REMARK 470 HIS B 396 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 470 ASP B 444 CG OD1 OD2 REMARK 470 GLU B 462 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS A 271 C - N - CA ANGL. DEV. = -17.1 DEGREES REMARK 500 VAL B 270 CA - C - N ANGL. DEV. = -16.1 DEGREES REMARK 500 VAL B 270 O - C - N ANGL. DEV. = 15.3 DEGREES REMARK 500 LYS B 271 C - N - CA ANGL. DEV. = -18.9 DEGREES REMARK 500 LYS B 271 CA - C - N ANGL. DEV. = -18.3 DEGREES REMARK 500 LYS B 271 O - C - N ANGL. DEV. = 11.6 DEGREES REMARK 500 THR B 272 C - N - CA ANGL. DEV. = -20.6 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -74.40 -112.17 REMARK 500 LYS A 274 -74.26 -63.67 REMARK 500 ASP A 276 78.12 -108.97 REMARK 500 ASP A 363 56.48 -155.74 REMARK 500 ASP A 381 64.01 -109.30 REMARK 500 ASP B 233 -158.42 -149.18 REMARK 500 LYS B 245 -88.12 -111.30 REMARK 500 GLU B 255 66.62 -107.03 REMARK 500 ASP B 276 65.00 -109.28 REMARK 500 GLU B 279 42.42 -75.18 REMARK 500 ASP B 363 55.13 -154.42 REMARK 500 ASP B 381 61.26 -110.49 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LYS A 271 13.22 REMARK 500 LYS B 271 12.39 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue FVC A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide FVC B 601 and LYS B REMARK 800 271 DBREF 7CC2 A 229 510 UNP P00519 ABL1_HUMAN 229 510 DBREF 7CC2 B 229 510 UNP P00519 ABL1_HUMAN 229 510 SEQADV 7CC2 MET A 201 UNP P00519 INITIATING METHIONINE SEQADV 7CC2 GLY A 202 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 203 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 204 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 205 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 206 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 207 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 208 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 209 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 210 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 211 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 212 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLY A 213 UNP P00519 EXPRESSION TAG SEQADV 7CC2 LEU A 214 UNP P00519 EXPRESSION TAG SEQADV 7CC2 VAL A 215 UNP P00519 EXPRESSION TAG SEQADV 7CC2 PRO A 216 UNP P00519 EXPRESSION TAG SEQADV 7CC2 ARG A 217 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLY A 218 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 219 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS A 220 UNP P00519 EXPRESSION TAG SEQADV 7CC2 MET A 221 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLU A 222 UNP P00519 EXPRESSION TAG SEQADV 7CC2 ASN A 223 UNP P00519 EXPRESSION TAG SEQADV 7CC2 LEU A 224 UNP P00519 EXPRESSION TAG SEQADV 7CC2 TYR A 225 UNP P00519 EXPRESSION TAG SEQADV 7CC2 PHE A 226 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLN A 227 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER A 228 UNP P00519 EXPRESSION TAG SEQADV 7CC2 MET B 201 UNP P00519 INITIATING METHIONINE SEQADV 7CC2 GLY B 202 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 203 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 204 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 205 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 206 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 207 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 208 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 209 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 210 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 211 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 212 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLY B 213 UNP P00519 EXPRESSION TAG SEQADV 7CC2 LEU B 214 UNP P00519 EXPRESSION TAG SEQADV 7CC2 VAL B 215 UNP P00519 EXPRESSION TAG SEQADV 7CC2 PRO B 216 UNP P00519 EXPRESSION TAG SEQADV 7CC2 ARG B 217 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLY B 218 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 219 UNP P00519 EXPRESSION TAG SEQADV 7CC2 HIS B 220 UNP P00519 EXPRESSION TAG SEQADV 7CC2 MET B 221 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLU B 222 UNP P00519 EXPRESSION TAG SEQADV 7CC2 ASN B 223 UNP P00519 EXPRESSION TAG SEQADV 7CC2 LEU B 224 UNP P00519 EXPRESSION TAG SEQADV 7CC2 TYR B 225 UNP P00519 EXPRESSION TAG SEQADV 7CC2 PHE B 226 UNP P00519 EXPRESSION TAG SEQADV 7CC2 GLN B 227 UNP P00519 EXPRESSION TAG SEQADV 7CC2 SER B 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 310 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 310 LEU VAL PRO ARG GLY SER HIS MET GLU ASN LEU TYR PHE SEQRES 3 A 310 GLN SER SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG SEQRES 4 A 310 THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN SEQRES 5 A 310 TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER SEQRES 6 A 310 LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET SEQRES 7 A 310 GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS SEQRES 8 A 310 GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL SEQRES 9 A 310 CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE SEQRES 10 A 310 MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS SEQRES 11 A 310 ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET SEQRES 12 A 310 ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS SEQRES 13 A 310 LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 A 310 LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE SEQRES 15 A 310 GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA SEQRES 16 A 310 HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO SEQRES 17 A 310 GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP SEQRES 18 A 310 VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR SEQRES 19 A 310 TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN SEQRES 20 A 310 VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG SEQRES 21 A 310 PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG SEQRES 22 A 310 ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE SEQRES 23 A 310 ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SEQRES 24 A 310 SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU SEQRES 1 B 310 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 310 LEU VAL PRO ARG GLY SER HIS MET GLU ASN LEU TYR PHE SEQRES 3 B 310 GLN SER SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG SEQRES 4 B 310 THR ASP ILE THR MET LYS HIS LYS LEU GLY GLY GLY GLN SEQRES 5 B 310 TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER SEQRES 6 B 310 LEU THR VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET SEQRES 7 B 310 GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA VAL MET LYS SEQRES 8 B 310 GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL SEQRES 9 B 310 CYS THR ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE SEQRES 10 B 310 MET THR TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS SEQRES 11 B 310 ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET SEQRES 12 B 310 ALA THR GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS SEQRES 13 B 310 LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 14 B 310 LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE SEQRES 15 B 310 GLY LEU SER ARG LEU MET THR GLY ASP THR TYR THR ALA SEQRES 16 B 310 HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO SEQRES 17 B 310 GLU SER LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP SEQRES 18 B 310 VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR SEQRES 19 B 310 TYR GLY MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN SEQRES 20 B 310 VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG SEQRES 21 B 310 PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG SEQRES 22 B 310 ALA CYS TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE SEQRES 23 B 310 ALA GLU ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SEQRES 24 B 310 SER SER ILE SER ASP GLU VAL GLU LYS GLU LEU HET FVC A 601 30 HET FVC B 601 30 HETNAM FVC [4-[5-[5-(DIMETHYLCARBAMOYL)PYRIDIN-3-YL]-1H-PYRROLO[2, HETNAM 2 FVC 3-B]PYRIDIN-3-YL]-2-METHYL-PHENYL]BORONIC ACID FORMUL 3 FVC 2(C22 H21 B N4 O3) FORMUL 5 HOH *45(H2 O) HELIX 1 AA1 GLU A 238 THR A 240 5 3 HELIX 2 AA2 THR A 277 LYS A 291 1 15 HELIX 3 AA3 ASN A 322 CYS A 330 1 9 HELIX 4 AA4 ASN A 336 LYS A 357 1 22 HELIX 5 AA5 ALA A 365 ARG A 367 5 3 HELIX 6 AA6 GLU A 373 HIS A 375 5 3 HELIX 7 AA7 PRO A 402 THR A 406 5 5 HELIX 8 AA8 ALA A 407 ASN A 414 1 8 HELIX 9 AA9 SER A 417 THR A 434 1 18 HELIX 10 AB1 ASP A 444 SER A 446 5 3 HELIX 11 AB2 GLN A 447 LYS A 454 1 8 HELIX 12 AB3 PRO A 465 TRP A 476 1 12 HELIX 13 AB4 ASN A 479 ARG A 483 5 5 HELIX 14 AB5 SER A 485 GLU A 499 1 15 HELIX 15 AB6 GLU B 238 THR B 240 5 3 HELIX 16 AB7 GLU B 279 LYS B 291 1 13 HELIX 17 AB8 ASN B 322 CYS B 330 1 9 HELIX 18 AB9 ASN B 336 LYS B 357 1 22 HELIX 19 AC1 ALA B 365 ARG B 367 5 3 HELIX 20 AC2 GLU B 373 HIS B 375 5 3 HELIX 21 AC3 PRO B 402 THR B 406 5 5 HELIX 22 AC4 ALA B 407 ASN B 414 1 8 HELIX 23 AC5 SER B 417 THR B 434 1 18 HELIX 24 AC6 ASP B 444 SER B 446 5 3 HELIX 25 AC7 GLN B 447 LYS B 454 1 8 HELIX 26 AC8 PRO B 465 TRP B 476 1 12 HELIX 27 AC9 ASN B 479 ARG B 483 5 5 HELIX 28 AD1 SER B 485 GLU B 499 1 15 SHEET 1 AA1 5 ILE A 242 LYS A 247 0 SHEET 2 AA1 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 AA1 5 LEU A 266 LEU A 273 -1 O VAL A 268 N GLY A 259 SHEET 4 AA1 5 PHE A 311 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 AA1 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 AA2 2 PHE A 359 ILE A 360 0 SHEET 2 AA2 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 AA3 2 CYS A 369 VAL A 371 0 SHEET 2 AA3 2 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 AA4 2 TYR A 393 THR A 394 0 SHEET 2 AA4 2 LYS A 415 PHE A 416 -1 O PHE A 416 N TYR A 393 SHEET 1 AA5 5 ILE B 242 LEU B 248 0 SHEET 2 AA5 5 VAL B 256 TRP B 261 -1 O VAL B 256 N LEU B 248 SHEET 3 AA5 5 LEU B 266 LEU B 273 -1 O VAL B 270 N TYR B 257 SHEET 4 AA5 5 PHE B 311 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 5 AA5 5 LEU B 301 CYS B 305 -1 N LEU B 302 O ILE B 314 SHEET 1 AA6 2 PHE B 359 ILE B 360 0 SHEET 2 AA6 2 SER B 385 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 AA7 2 CYS B 369 VAL B 371 0 SHEET 2 AA7 2 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 AA8 2 TYR B 393 THR B 394 0 SHEET 2 AA8 2 LYS B 415 PHE B 416 -1 O PHE B 416 N TYR B 393 LINK NZ LYS A 271 C21 FVC A 601 1555 1555 1.26 LINK NZ LYS B 271 C21 FVC B 601 1555 1555 1.26 CISPEP 1 PRO A 309 PRO A 310 0 -3.48 CISPEP 2 PRO B 309 PRO B 310 0 -6.00 SITE 1 AC1 9 ALA A 269 LYS A 271 THR A 315 GLU A 316 SITE 2 AC1 9 MET A 318 GLY A 321 ASN A 322 LEU A 370 SITE 3 AC1 9 PHE A 382 SITE 1 AC2 15 LEU B 248 TYR B 253 VAL B 256 ALA B 269 SITE 2 AC2 15 VAL B 270 THR B 272 PHE B 311 TYR B 312 SITE 3 AC2 15 ILE B 313 THR B 315 GLU B 316 MET B 318 SITE 4 AC2 15 ASN B 322 LEU B 370 PHE B 382 CRYST1 116.489 127.939 56.760 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008585 0.000000 0.000000 0.00000 SCALE2 0.000000 0.007816 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017618 0.00000